ARTICLE | Company News
Array BioPharma, Asahi Kasei Pharma deal
April 18, 2016 7:00 AM UTC
Array granted Asahi exclusive rights in Japan, Korea, Taiwan and China to commercialize and develop ARRY-954 and other select neurotrophic tyrosine kinase receptor 1 ( TrkA; NTRK1) inhibitors to tr...